BSE Live
Oct 31, 16:01Prev. Close
1.50
Open Price
1.50
Bid Price (Qty.)
1.55 (333875)
Offer Price (Qty.)
1.56 (113071)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Remedium Lifecare (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.04 | 3.25 | 15.07 | 2.99 | 1.33 | |
| Diluted EPS (Rs.) | 0.04 | 3.25 | 15.07 | 2.99 | 1.33 | |
| Cash EPS (Rs.) | 0.04 | 3.25 | 15.49 | 3.20 | 1.50 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 1.07 | 4.26 | 28.79 | 13.72 | 10.72 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 1.07 | 4.26 | 28.79 | 13.72 | 10.72 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 5.52 | 400.96 | 1,416.21 | 1,402.20 | 250.09 | |
| PBDIT/Share (Rs.) | 0.22 | 5.40 | 20.75 | 4.74 | 1.98 | |
| PBIT/Share (Rs.) | 0.22 | 5.39 | 20.33 | 4.53 | 1.81 | |
| PBT/Share (Rs.) | 0.09 | 5.01 | 20.54 | 4.24 | 1.81 | |
| Net Profit/Share (Rs.) | 0.04 | 3.25 | 15.07 | 2.99 | 1.33 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 4.04 | 1.34 | 1.46 | 0.33 | 0.79 | |
| PBIT Margin (%) | 4.02 | 1.34 | 1.43 | 0.32 | 0.72 | |
| PBT Margin (%) | 1.64 | 1.24 | 1.45 | 0.30 | 0.72 | |
| Net Profit Margin (%) | 0.68 | 0.80 | 1.06 | 0.21 | 0.53 | |
| Return on Networth / Equity (%) | 3.53 | 76.19 | 52.35 | 21.82 | 12.45 | |
| Return on Capital Employed (%) | 20.67 | 126.46 | 70.63 | 33.04 | 4.54 | |
| Return on Assets (%) | 0.09 | 1.68 | 0.47 | 0.48 | 1.24 | |
| Total Debt/Equity (X) | 26.36 | 1.34 | 0.00 | 0.00 | 2.72 | |
| Asset Turnover Ratio (%) | 0.13 | 2.61 | 0.74 | 3.85 | 233.65 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.03 | 1.02 | 1.01 | 1.02 | 1.59 | |
| Quick Ratio (X) | 0.85 | 0.95 | 1.00 | 0.64 | 1.46 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 11.46 | 28.97 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,213.41 | 1,149.86 | 243.68 | 48.42 | 25.53 | |
| EV/Net Operating Revenue (X) | 5.45 | 0.28 | 0.48 | 0.10 | 0.28 | |
| EV/EBITDA (X) | 134.94 | 21.14 | 32.62 | 28.39 | 35.81 | |
| MarketCap/Net Operating Revenue (X) | 0.33 | 0.27 | 0.52 | 0.10 | 0.18 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.70 | 25.46 | 25.62 | 10.10 | 4.11 | |
| Price/Net Operating Revenue | 0.33 | 0.27 | 0.52 | 0.10 | 0.18 | |
| Earnings Yield | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 |
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
19.08.2024
Remedium Lifeca Standalone June 2024 Net Sales at Rs 77.70 crore, down 76.49% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
19.08.2024
Remedium Lifeca Standalone June 2024 Net Sales at Rs 77.70 crore, down 76.49% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017